Voss Capital’s Aptose Biosciences, Inc. APTO Stock Holding History

Voss Capital’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-47	Closed	-$29K	–	84
2020 Q1	$29K	Buy	+47	New	+$140K	0.04%	50

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Voss Capital's APTO Position: Q3 2023 in Review

Voss Capital sold out of Aptose Biosciences, Inc. (APTO) in Q3 2023, closing a stake of 488 shares — an estimated $67.9K sold.

Voss Capital first reported a position in APTO in Q4 2019 and held it in 15 quarters. The position peaked at $4.1M in Q3 2020. 25 funds tracked by Wall St. Rank hold APTO as of Q3 2023.

Voss Capital reported no remaining Aptose Biosciences, Inc. position as of Q3 2023 after selling out during the quarter.
Voss Capital sold 488 Aptose Biosciences, Inc. shares in Q3 2023, an estimated $67.9K.
Voss Capital first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 15 quarters.
Voss Capital's Aptose Biosciences, Inc. position peaked at $4.1M in Q3 2020.
25 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2023.

Based on Voss Capital's 13F filing for Q3 2023, filed 19 Oct 2023.